Chemical inhibitors of SNRNP48 target various aspects of the splicing machinery, with a focus on disrupting the normal function of SNRNP48 in the spliceosome complex. Pladienolide B, Sudemycin D6, and Spliceostatin A directly bind to components of the spliceosome. For instance, Pladienolide B interacts with the SF3b complex, a critical component of the spliceosome, leading to inhibition of SNRNP48's role in splicing by preventing proper spliceosome assembly. Similarly, Spliceostatin A binds to the spliceosome, thereby altering pre-mRNA splicing and obstructing the functional integration of SNRNP48 into the spliceosomal complex. These interactions effectively halt the splicing cycle at stages where SNRNP48 is essential, thereby inhibiting its function.
Other inhibitors, like Madrasin and E7107, selectively target spliceosome assembly or specific snRNP particles, impacting SNRNP48's participation in RNA splicing. Madrasin, for instance, disrupts the assembly of the spliceosome, preventing SNRNP48 from performing its role in the splicing of pre-mRNA. E7107 targets the U2 snRNP component, which is a necessary collaborator of SNRNP48 in the splicing process. Additionally, Meayamycin and Isoginkgetin disrupt the spliceosome's function, which impairs SNRNP48's splicing activity. Meayamycin binds to the core spliceosome, inhibiting its function, and Isoginkgetin interferes with spliceosome assembly. Plitidepsin, Herboxidiene, Tetrocarcin A, and FR901464 exert their inhibitory effects by binding to various spliceosomal components, which in turn, impede the role of SNRNP48 in the splicing process. Sinefungin, while not directly targeting the spliceosome, inhibits RNA methyltransferase activity, which is crucial for mRNA processing and maturation, processes that require the functional action of SNRNP48. This broad spectrum of inhibitors showcases the diverse mechanisms by which the splicing activity of SNRNP48 can be inhibited, underscoring the complexity of the splicing process and the multiple points at which it can be disrupted.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
Inhibits the spliceosome, of which SNRNP48 is a component, by binding to SF3b, leading to the inhibition of SNRNP48's splicing function. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
A splicing inhibitor that can interfere with spliceosome assembly, thus inhibiting the splicing activity of SNRNP48. | ||||||
Madrasin | 374913-63-0 | sc-507563 | 100 mg | $750.00 | ||
Selectively targets spliceosome assembly, thereby inhibiting SNRNP48's role in RNA splicing. | ||||||
Herboxidiene | 142861-00-5 | sc-506378 | 1 mg | $1009.00 | ||
Inhibits RNA splicing by targeting spliceosomal components, potentially disrupting SNRNP48's function. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
Binds to SF3b complex and inhibits splicing activity, affecting SNRNP48's role in spliceosome function. | ||||||
FR901464 | 146478-72-0 | sc-507352 | 5 mg | $1800.00 | ||
Targets the splicing machinery, and thus can inhibit the function of SNRNP48 in RNA splicing. | ||||||
Sinefungin | 58944-73-3 | sc-203263 sc-203263B sc-203263C sc-203263A | 1 mg 100 mg 1 g 10 mg | $266.00 $5100.00 $39576.00 $690.00 | 4 | |
Acts as an inhibitor of RNA methyltransferase, which can indirectly inhibit SNRNP48 involved in mRNA processing and maturation. | ||||||